X

Thank you for sharing!

Your article was successfully shared with the contacts you provided.
The study was not meant to assess whether the spending on drugs and services is cost-effective, although the findings do merit that discussion. (Photo: Rido/Shutterstock.com)

New research indicates that care for the 15 most prevalent types of cancer in the United States cost approximately $156.2 billion in 2018. Medication was the top expense, with drugs for breast, lung, lymphoma and colorectal cancers incurring the most costs.

A team of researchers at the Penn State College of Medicine examined a database that included statistics on cancer care for 402,115 privately insured cancer patients in the United States under the age of 65 in an effort to better understand how money is spent on cancer care.

Complete your profile to continue reading and get FREE access to BenefitsPRO.com, part of your ALM digital membership.

Your access to unlimited BenefitsPRO.com content isn’t changing.
Once you are an ALM digital member, you’ll receive:

  • Critical BenefitsPRO.com information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events.
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com

Already have an account?

 

BenefitsPRO

Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join BenefitsPRO.com now!

  • Unlimited access to BenefitsPRO.com - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
  • Exclusive discounts on BenefitsPRO.com and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO

Copyright © 2021 ALM Media Properties, LLC. All Rights Reserved.